180 Life Sciences Plans $425M Ethereum Treasury

Nasdaq-listed 180 Life Sciences is reportedly raising $425 million via private financing to create an Ethereum treasury, prompting plans to rename the company to ETHZilla Corporation.

The unverified transaction, involving prominent crypto investors, underscores the potential shift of traditional firms towards significant cryptocurrency investment, though official confirmations remain absent.

180 Life Sciences’ Alleged Ethereum Strategy Raises Questions

Reports from ChainCatcher suggest 180 Life Sciences plans to raise $425 million for an Ethereum treasury, with a name change to ETHZilla Corporation. The transaction allegedly involves major investors, including Harbour Island and Electric Capital. However, no official statements from the company or included investors back these claims as of now. Furthermore, without on-chain evidence or regulatory filings, the accuracy of these reports is uncertain. The lack of confirmation from involved parties leaves the details in the realm of speculation, highlighting the need for verified communication.

The proposed treasury aims to increase Ethereum’s institutional adoption, potentially influencing its market valuation. Yet, the absence of official validation has rendered any market impact currently untraceable. ETH remains unaffected by fluctuating narratives around the reported transaction. No major statements from key figures or financial institutions have emerged, leaving the community awaiting clarity. The absence of confirmed reactions highlights the cautious stance stakeholders are adopting regarding unverified reports. Notably, “based on the information provided, it appears that there are currently no officially corroborated quotes or statements from primary sources regarding the alleged transaction involving 180 Life Sciences and the supposed ETH treasury funding“, drawing attention to the speculative nature of the current discussions.

The proposed treasury aims to increase Ethereum’s institutional adoption, potentially influencing its market valuation. Yet, the absence of official validation has rendered any market impact currently untraceable. ETH remains unaffected by fluctuating narratives around the reported transaction. No major statements from key figures or financial institutions have emerged, leaving the community awaiting clarity.

Implications of Unverified Corporate Crypto Acquisitions

Did you know? Historically, previous instances of public companies investing heavily in cryptocurrencies—like MicroStrategy’s Bitcoin strategy—have led to marked price reactions and increased institutional flows.

According to CoinMarketCap, Ethereum (ETH) maintained a price of $3,780.89 with a market cap of $456.39 billion. Over the past 90 days, ETH has shown a substantial gain of 114.62%. The 24-hour trading volume reached $34.70 billion, experiencing a minor decrease of 2.35% as of July 29, 2025. Price movements over recent periods suggest significant volatility within a burgeoning market climate.

Coincu research experts point out that without concrete evidence of the reported financial actions by 180 Life Sciences, the current Ethereum market impact remains speculative. Drawing parallels with past events, historical corporate moves to integrate digital assets, backed by verified announcements, have often curbed investor hesitancy and led to substantive market participation. Future confirmations could dramatically alter future Ethereum valuation calculations and investment strategies. Reports of major Ethereum financial vehicles continue to circulate within the industry.